November 15, 2013
CSIMC Healthcare Provider Rep. Hideki Adachi Takeda Pharmaceutical’s anti-obesity medicine OBLEAN Tablets 120 mg (cetilistat) failed to clear a key health ministry advisory committee for its NHI price listing on November 19, as panel members raised rare objections to the...read more